<Record>
<Term>TPI 287</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<ParentTerm>Taxane Compound</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Drug or Chemical by Structure/Organic Chemical/Lipid/Terpene Compound/Taxane Compound/TPI 287,/NCIThesaurus/Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Antineoplastic Agent/Antimitotic Agent/Tubulin Binding Agent/Taxane-Pocket Binding Agent/TPI 287</ClassificationPath>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>Antineoplastic Agent</BroaderTerm>
<BroaderTerm>NCIThesaurus</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>Antimitotic Agent</BroaderTerm>
<BroaderTerm>Terpene Compound</BroaderTerm>
<BroaderTerm>Drug or Chemical by Structure</BroaderTerm>
<BroaderTerm>Taxane-Pocket Binding Agent</BroaderTerm>
<BroaderTerm>TPI 287</BroaderTerm>
<BroaderTerm>Organic Chemical</BroaderTerm>
<BroaderTerm>Lipid</BroaderTerm>
<BroaderTerm>Taxane Compound</BroaderTerm>
<BroaderTerm>Tubulin Binding Agent</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<BroaderTerm>TPI 287,</BroaderTerm>
<Synonym>TPI 287</Synonym>
<Description>A synthetic, third generation taxane with potential antineoplastic activity. TPI 287 binds to tubulin and stabilizes microtubules, resulting in inhibition of microtubule assembly/disassembly dynamics, cell cycle arrest at the G2/M phase, and apoptosis.</Description>
<Source>NCI Thesaurus</Source>
</Record>
